About Nemaura Medical (OTCMKTS:NMRD)
Nemaura Medical, Inc. is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company's focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source. CGM through a non-invasive patch can enable early detection of subtle changes in blood glucose levels. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a CGM, named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes, and may also be used to screen pre-diabetic patients. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm.
Industry, Sector and Symbol
Industry Medical Equipment, Supplies & Distribution
Trailing P/E Ratio-535
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-31.25%
Return on Assets-21.89%
Nemaura Medical (OTCMKTS:NMRD) Frequently Asked Questions
What is Nemaura Medical's stock symbol?
Nemaura Medical trades on the OTCMKTS under the ticker symbol "NMRD."
How were Nemaura Medical's earnings last quarter?
Nemaura Medical Inc (OTCMKTS:NMRD) announced its quarterly earnings results on Friday, February, 9th. The company reported $0.00 earnings per share (EPS) for the quarter. View Nemaura Medical's Earnings History.
Who are some of Nemaura Medical's key competitors?
Some companies that are related to Nemaura Medical include Cardiovascular Systems (CSII), Exactech (EXAC), Landauer (LDR), STAAR Surgical (STAA), AtriCure (ATRC), Meridian Bioscience (VIVO), Cryolife (CRY), Consort Medical (CSRT), Invacare (IVC), Syneron Medical (ELOS), SurModics (SRDX), Antares Pharma (ATRS), Utah Medical Products (UTMD), Transenterix (TRXC), Palomar Medical Technologies (PMTI), InspireMD (NSPR), Sientra (SIEN) and CRH Medical (CRHM).
Who are Nemaura Medical's key executives?
Nemaura Medical's management team includes the folowing people:
- Dewan Fazlul Hoque Chowdhury, Chairman of the Board, President, Chief Executive Officer (Age 42)
- Iain Anderson, Chief Financial Officer
- Karrar Khan, Director of Product Development (Age 79)
- David Scott, Director of Commercial Development and Licensing (Age 64)
- Richard Toon, Business and Technical Development Manager (Age 45)
- Bashir Timol, Director (Age 40)
- Timothy Johnson, Independent Director
- Thomas Moore, Independent Director
- Salim Natha, Independent Director
How do I buy Nemaura Medical stock?
Shares of Nemaura Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Nemaura Medical's stock price today?
One share of Nemaura Medical stock can currently be purchased for approximately $5.35.
How big of a company is Nemaura Medical?
Nemaura Medical has a market capitalization of $391.84 million.
How can I contact Nemaura Medical?
Nemaura Medical's mailing address is Advanced Technology Innovation Centre Loughborough Univ Science & Enterprise, LOUGHBOROUGH, LE11 3QF, United Kingdom. The company can be reached via phone at +44-1509-222912.
MarketBeat Community Rating for Nemaura Medical (NMRD)MarketBeat's community ratings are surveys of what our community members think about Nemaura Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Nemaura Medical (OTCMKTS:NMRD) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Nemaura Medical (OTCMKTS:NMRD) Earnings History and Estimates Chart
Nemaura Medical (OTCMKTS NMRD) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Nemaura Medical (OTCMKTS:NMRD) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Nemaura Medical (OTCMKTS:NMRD)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Nemaura Medical (OTCMKTS NMRD)
No insider trades for this company have been tracked by MarketBeat.com
Nemaura Medical (OTCMKTS NMRD) News Headlines
Nemaura Medical (OTCMKTS:NMRD) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Nemaura Medical (OTCMKTS NMRD) Stock Chart for Thursday, February, 22, 2018